Literature DB >> 27174997

Regulatory T cells ameliorate intracerebral hemorrhage-induced inflammatory injury by modulating microglia/macrophage polarization through the IL-10/GSK3β/PTEN axis.

Kai Zhou1, Qi Zhong1, Yan-Chun Wang1, Xiao-Yi Xiong1, Zhao-You Meng1, Ting Zhao1, Wen-Yao Zhu1, Mao-Fan Liao1, Li-Rong Wu1, Yuan-Rui Yang1, Juan Liu1, Chun-Mei Duan1, Jie Li1, Qiu-Wen Gong1, Liang Liu1, Mei-Hua Yang1, Ao Xiong2, Jian Wang3, Qing-Wu Yang1.   

Abstract

Inflammation mediated by the peripheral infiltration of inflammatory cells plays an important role in intracerebral hemorrhage (ICH) induced secondary injury. Previous studies have indicated that regulatory T lymphocytes (Tregs) might reduce ICH-induced inflammation, but the precise mechanisms that contribute to ICH-induced inflammatory injury remain unclear. Our results show that the number of Tregs in the brain increases after ICH. Inducing Tregs deletion using a CD25 antibody or Foxp3DTR-mice increased neurological deficient scores (NDS), the level of inflammatory factors, hematoma volumes, and neuronal degeneration. Meanwhile, boosting Tregs using a CD28 super-agonist antibody reduced the inflammatory injury. Furthermore, Tregs depletion shifted microglia/macrophage polarization toward the M1 phenotype while boosting Tregs shifted this transition toward the M2 phenotype. In vitro, a transwell co-culture model of microglia and Tregs indicated that Tregs changed the polarization of microglia, decreased the expression of MHC-II, IL-6, and TNF-α and increased CD206 expression. IL-10 originating from Tregs mediated the microglia polarization by increasing the expression of Glycogen Synthase Kinase 3 beta (GSK3β), which phosphorylates and inactivates Phosphatase and Tensin homologue (PTEN) in microglia, TGF-β did not participate in this conversion. Thus, Tregs ameliorated ICH-induced inflammatory injury by modulating microglia/macrophage polarization toward the M2 phenotype through the IL-10/GSK3β/PTEN axis.

Entities:  

Keywords:  Intracerebral hemorrhage; T-cells; inflammation; macrophages; microglia

Mesh:

Substances:

Year:  2016        PMID: 27174997      PMCID: PMC5363473          DOI: 10.1177/0271678X16648712

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  45 in total

Review 1.  Regulatory T cells in the central nervous system.

Authors:  Daniel E Lowther; David A Hafler
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Fingolimod provides long-term protection in rodent models of cerebral ischemia.

Authors:  Ying Wei; Muge Yemisci; Hyung-Hwan Kim; Lai Ming Yung; Hwa Kyoung Shin; Seo-Kyoung Hwang; Shuzhen Guo; Tao Qin; Nafiseh Alsharif; Volker Brinkmann; James K Liao; Eng H Lo; Christian Waeber
Journal:  Ann Neurol       Date:  2010-11-12       Impact factor: 10.422

3.  Toll-like receptor 4 antagonist attenuates intracerebral hemorrhage-induced brain injury.

Authors:  Yan-Chun Wang; Peng-Fei Wang; Huang Fang; Jing Chen; Xiao-Yi Xiong; Qing-Wu Yang
Journal:  Stroke       Date:  2013-07-09       Impact factor: 7.914

4.  Amplification of regulatory T cells using a CD28 superagonist reduces brain damage after ischemic stroke in mice.

Authors:  Shin-Young Na; Eva Mracsko; Arthur Liesz; Thomas Hünig; Roland Veltkamp
Journal:  Stroke       Date:  2014-11-06       Impact factor: 7.914

Review 5.  Complications of intracerebral haemorrhage.

Authors:  Joyce S Balami; Alastair M Buchan
Journal:  Lancet Neurol       Date:  2012-01       Impact factor: 44.182

6.  Intracerebral hemorrhage leads to infiltration of several leukocyte populations with concomitant pathophysiological changes.

Authors:  Matthew C Loftspring; Jeremiah McDole; Aigang Lu; Joseph F Clark; Aaron J Johnson
Journal:  J Cereb Blood Flow Metab       Date:  2008-10-01       Impact factor: 6.200

Review 7.  Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation.

Authors:  Yu Zhou; Yanchun Wang; Jian Wang; R Anne Stetler; Qing-Wu Yang
Journal:  Prog Neurobiol       Date:  2013-11-26       Impact factor: 11.685

8.  Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages.

Authors:  Xiurong Zhao; Guanghua Sun; Jie Zhang; Roger Strong; Weitao Song; Nicole Gonzales; James C Grotta; Jaroslaw Aronowski
Journal:  Ann Neurol       Date:  2007-04       Impact factor: 10.422

9.  Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage.

Authors:  Sen Lin; Qing Yin; Qi Zhong; Feng-Lin Lv; Yu Zhou; Jing-Qi Li; Jing-Zhou Wang; Bing-yin Su; Qing-Wu Yang
Journal:  J Neuroinflammation       Date:  2012-03-06       Impact factor: 8.322

10.  Functional differences between microglia and monocytes after ischemic stroke.

Authors:  Rodney M Ritzel; Anita R Patel; Jeremy M Grenier; Joshua Crapser; Rajkumar Verma; Evan R Jellison; Louise D McCullough
Journal:  J Neuroinflammation       Date:  2015-05-29       Impact factor: 8.322

View more
  64 in total

Review 1.  Systemic inflammation in hemorrhagic strokes - A novel neurological sign and therapeutic target?

Authors:  Aisha R Saand; Fang Yu; Jun Chen; Sherry H-Y Chou
Journal:  J Cereb Blood Flow Metab       Date:  2019-04-08       Impact factor: 6.200

2.  GSK-3β Inhibition Induced Neuroprotection, Regeneration, and Functional Recovery After Intracerebral Hemorrhagic Stroke.

Authors:  Yingying Zhao; Zheng Zachory Wei; James Ya Zhang; Yongbo Zhang; Soonmi Won; Jinmei Sun; Shan Ping Yu; Jimei Li; Ling Wei
Journal:  Cell Transplant       Date:  2017-02-14       Impact factor: 4.064

3.  The intracerebral hemorrhage blood transcriptome in humans differs from the ischemic stroke and vascular risk factor control blood transcriptomes.

Authors:  Boryana Stamova; Bradley P Ander; Glen Jickling; Farah Hamade; Marc Durocher; Xinhua Zhan; Da Zhi Liu; Xiyuan Cheng; Heather Hull; Alan Yee; Kwan Ng; Natasha Shroff; Frank R Sharp
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-13       Impact factor: 6.200

Review 4.  Modulators of microglial activation and polarization after intracerebral haemorrhage.

Authors:  Xi Lan; Xiaoning Han; Qian Li; Qing-Wu Yang; Jian Wang
Journal:  Nat Rev Neurol       Date:  2017-05-19       Impact factor: 42.937

Review 5.  Promises and limitations of immune cell-based therapies in neurological disorders.

Authors:  Xiaoming Hu; Rehana K Leak; Angus W Thomson; Fang Yu; Yuguo Xia; Lawrence R Wechsler; Jun Chen
Journal:  Nat Rev Neurol       Date:  2018-09       Impact factor: 42.937

6.  Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  J Cereb Blood Flow Metab       Date:  2020-09-14       Impact factor: 6.200

Review 7.  Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair.

Authors:  Wei Cai; Tuo Yang; Huan Liu; Lijuan Han; Kai Zhang; Xiaoming Hu; Xuejing Zhang; Ke-Jie Yin; Yanqin Gao; Michael V L Bennett; Rehana K Leak; Jun Chen
Journal:  Prog Neurobiol       Date:  2017-10-12       Impact factor: 11.685

8.  Alternative activation-skewed microglia/macrophages promote hematoma resolution in experimental intracerebral hemorrhage.

Authors:  Che-Feng Chang; Jieru Wan; Qiang Li; Stephen C Renfroe; Nicola M Heller; Jian Wang
Journal:  Neurobiol Dis       Date:  2017-03-30       Impact factor: 5.996

Review 9.  The evolving role of neuro-immune interaction in brain repair after cerebral ischemic stroke.

Authors:  Xin Wang; Wei Xuan; Zi-Yu Zhu; Yan Li; Hao Zhu; Ling Zhu; Dan-Yun Fu; Li-Qun Yang; Pei-Ying Li; Wei-Feng Yu
Journal:  CNS Neurosci Ther       Date:  2018-10-22       Impact factor: 5.243

10.  Adoptive Regulatory T-cell Therapy Attenuates Perihematomal Inflammation in a Mouse Model of Experimental Intracerebral Hemorrhage.

Authors:  Lei-Lei Mao; Hui Yuan; Wen-Wen Wang; Yu-Jing Wang; Ming-Feng Yang; Bao-Liang Sun; Zong-Yong Zhang; Xiao-Yi Yang
Journal:  Cell Mol Neurobiol       Date:  2016-09-27       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.